North....Ordinarily we should hope that AMRN has increased earnings to enhance the stock price...but at this juncture, what matters even more is the occurance of events that would interest a BP in buying the company.
North, Given that Alex Denner essentially sold The Medicines Company to NVS, one would hope his relationship with NVS is such that they would at least listen to what he may propose, and would be able to disclose to NVS the new formulation that could be the game changer...Most especially if NVS were to take the idea and run with it!
Market Data 
Markets 
AI
